© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
AN2 Therapeutics, Inc. (ANTX) stock surged +1.96%, trading at $1.04 on NASDAQ, up from the previous close of $1.02. The stock opened at $1.01, fluctuating between $1.01 and $1.08 in the recent session.
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Employees | 41 |
Beta | -0.214 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
AN2 Therapeutics, Inc. (NASDAQ: ANTX) stock price is $1.04 in the last trading session. During the trading session, ANTX stock reached the peak price of $1.08 while $1.01 was the lowest point it dropped to. The percentage change in ANTX stock occurred in the recent session was 1.96% while the dollar amount for the price change in ANTX stock was $0.02.
The NASDAQ listed ANTX is part of Biotechnology industry that operates in the broader Healthcare sector. AN2 Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Kevin Krause B.S., M.B.A.
Chief Strategy Officer
Mr. Josh Eizen
Chief Legal Officer & Sec.
Ms. Lucy O. Day CPA
Chief Financial Officer, Sec. & Treasurer
Mr. Joshua Eizen J.D.
Chief Legal Officer & Sec.
Mr. Joseph S. Zakrzewski
Independent Investor & Independent Chairman
Mr. Eric E. Easom
Co-founder, Chief Executive Officer, Pres & Director
Dr. Sanjay Chanda Ph.D.
Chief Devel. Officer
Ms. Jennifer Huber
Senior Vice President of Regulatory Affairs & Quality
Dr. Paul Eckburg M.D.
Chief Medical Officer
Dr. Michael R. K. Alley Ph.D.
Co-Founder & Head of Biology
Dr. George Harrison Talbot FACP, M.D.
Co-Founder & Senior Clinical Advisor
ANTX's closing price is 19.54% higher than its 52-week low of $0.87 where as its distance from 52-week high of $22.22 is -95.32%.
Number of ANTX employees currently stands at 41.
Official Website of ANTX is: https://www.an2therapeutics.com
ANTX could be contacted at phone 650 331 9090 and can also be accessed through its website. ANTX operates from 1800 El Camino Real, Menlo Park, CA 94027, United States.
ANTX stock volume for the day was 245.83K shares. The average number of ANTX shares traded daily for last 3 months was 600.83K.
The market value of ANTX currently stands at $31.04M with its latest stock price at $1.04 and 29.84M of its shares outstanding.